Biodesix, Inc.
BDSX
$15.86
$0.563.66%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 17.86% | 9.77% | 7.71% | 14.11% | 17.67% |
| Total Depreciation and Amortization | -1.78% | 1.83% | 8.20% | 7.64% | 4.83% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -41.15% | -37.48% | -44.15% | -34.42% | -18.35% |
| Change in Net Operating Assets | 101.54% | 97.07% | 93.21% | -1,118.90% | -291.69% |
| Cash from Operations | 52.17% | 50.48% | 40.13% | -37.53% | -112.72% |
| Capital Expenditure | 91.98% | 81.17% | 89.12% | 80.16% | 85.91% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 31.43% | 6.04% | -23.21% | -53.95% | -46.85% |
| Cash from Investing | 88.28% | 78.71% | 87.43% | 78.86% | 85.08% |
| Total Debt Issued | -- | 0.00% | 0.00% | -- | -- |
| Total Debt Repaid | 58.82% | 43.14% | 24.00% | 10.00% | -4.08% |
| Issuance of Common Stock | -86.11% | -92.03% | -99.20% | 89.74% | 94.99% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 66.96% | 81.30% | 90.46% | 38.49% | 56.89% |
| Cash from Financing | -68.46% | -80.36% | -88.54% | 58.80% | 78.69% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -18,507.69% | -227.97% | -186.62% | 144.34% | 99.77% |